Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 4, 2012, Pages 361-369

  Zhan, Qian ^a   Shen, Bai Yong ^a   Deng, Xia Xing ^a   Zhu, Zhe Cheng ^a   Chen, Hao ^a   Peng, Chen Hong ^a   Li, Hong Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Cirrhosis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; CYTOKERATIN; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; PROTEIN P53;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RECURRENCE; CHINA; CLINICAL ARTICLE; COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH CENTER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATINS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84866018334     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0417-2     Document Type: Article

References (28)

1. Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology. 1993;18:1090-5.
2. Choi BI, Han JK, Kim YI, et al. Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging. 1994;19:43-6.
3. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124-35.
4. Janargin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma. Demographic, clinical and prognostic factors. Cancer. 2002;94:2040-6.
5. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg. 2003;138: 86-90.
6. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 1996;11:758-64.
7. Yano Y, Yamamoto J, Kosuge Y, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283-7.
8. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumours of the liver. In: World Health Organization International Histologic Classification of Tumours, 2nd ed. Berlin: Springer; 1994.
9. Fuji H, Zhu XG, Matsumoto T, et al. Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol. 2000;31:1011-7.
10. Tickoo SK, Zee SY, Obiekwe S, et al. Combined hepatocellularcholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol. 2002;26:989-97.
11. Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular and cholangiocarcinoma. Ann Surg Oncol. 2009;16:623-9.
12. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular and cholangiocarcinoma. Am J Surg. 2005;189:120-5.
13. Itamoto T, Asahara T, Katayama K, et al. Double cancer - hepatocellular carcinoma and intrahepatic cholangiocarcinoma with a spindle-cell variant. J Hepatobiliary Pancreat Surg. 1999;6:422-6.
14. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver. 1995;15:9-15.
15. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellularcholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol. 1998;13:34-40.
16. Laurent-Puig P, Flejou JF, Fabre M, et al. Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology. 1992;16:1171-5.
17. Collier JD, Carpenter M, Burt AD, Bassendine MF. Expression of mutant p53 protein in hepatocellular carcinoma. Gut. 1994;35:98-100.
18. Jeyarajah R, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg. 1998; 5:48-51.
19. Lin G, Toh CH, Wu RC, et al. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract. 2008;62:1199-205.
20. Panjala C, Senecal DL, Bridges MD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular- cholangiocarcinoma. Am J Transplant. 2010;10:1263-7.
21. Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2010;45:69-75.
22. Nakamura S, Suzuki S, Sakaguchi T, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer. 1996;78:1671-6.
23. Portolani N, Baiocchi GL, Coniglio A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol. 2008;15:1880-90.
24. Lee CC, Wu CY, Chen JT, et al. Comparing combined hepatocellular- cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study. Hepatogastroenterology. 2002;49:1487-90.
25. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1999;334:693-9.
26. Robles R, Figueras J, Turrión VS, et al. Liver transplantation for peripheral cholangiocarcinoma: Spanish experience. Transplant Proc. 2003;35:1823-4.
27. Chan AC, Lo CM, Ng IO, et al. Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg. 2007;30:143-6.
28. Tang D, Nagano H, Nakamura M, et al. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg. 2006;10:987-98.